HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe

Western Culture and Diet Are Shifting the Diabetic Market into Hyperdrive

July 1, 2007 by HME Business

New research was released last week showing that business is booming in diabetes diagnostics, and it’s projected to boom even more between now and 2025. A report by Global Industry Analysts forecasts global diagnostics spending to zoom past the $15 billion mark by 2010 and will expand at an annual clip of 10 to 13 percent thereafter. Nearly 90 percent of the market lies in the United States, Europe and Asia.

The report, titled Diabetes Diagnostics: A Global Strategic Business Report, links the diabetes explosion to the West’s aging population, its population growth, growing disposable income, unhealthy lifestyles and diet, and genetic predisposition to diabetes.

The numbers tell the story. In 2000, some 150 million adults were living with diabetes. That number will double by 2025 to 300 million, a growth rate of 30 percent in developed nations and 125 percent elsewhere. The demand for diabetic monitoring and treatment products and services will expand accordingly; blood-glucose test strips, monitors, and lancet devices will be big sellers.

Related Articles Read More >

More HCPCS Codes to Be Added to Medicare Prior Authorization Process in October
Prior authorization will be required for eight additional codes for dates of service of Oct. 28 and later.
M&A Update, Part 2: What Makes a Good Investment or Acquisition?
At the HME Business FUTURE conference, experts on mergers and acquisitions took the stage.
Frazier Healthcare Acquires MatrixCare, Appoints CEO
MatrixCare was owned by Resmed.
M&A Update: Is DME Still Attractive to Investors?
Panelists at the HME Business FUTURE conference on what’s changed in mergers and acquisitions interest.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
    • FUTURE Conference
  • Awards
  • Advertise
  • Subscribe